Oxycodone/acetaminophen at low dosage: An alternative pain treatment for patients with rheumatoid arthritis

Journal of Opioid Management

Volumn 6, Issue 1, 2010, Pages 40-46

  Raffaeli, William ^a   Pari, Claudia ^a   Corvetta, Angelo ^a   Sarti, Donatella ^a   Di Sabatino, Valentina ^b   Biasi, Giovanni ^b   Galeazzi, Maurizio ^b  

^a Infermi Hospital   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Association oxicodone acetaminophen; Opioids; Pain control; Rheumatoid arthritis

Indexed keywords

ANTIEMETIC AGENT; C REACTIVE PROTEIN; CORTISONE; DEFLAZACORT; HYDROXYCHLOROQUINE; LAXATIVE; LEFLUNOMIDE; MACROGOL; METHOTREXATE; METHYLPREDNISOLONE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE PLUS PARACETAMOL; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ANALGESIA; ANOREXIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISABILITY; DISEASE ACTIVITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INAPPETENCE; LOW DRUG DOSE; MALE; NAUSEA; OUTCOME ASSESSMENT; PHYSICAL DISEASE BY BODY FUNCTION; PROPHYLAXIS; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SOMNOLENCE; STIPSIS; TREATMENT RESPONSE; VERTIGO; VISUAL ANALOG SCALE; VOMITING; XEROSTOMIA;

ACETAMINOPHEN; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ARTHRALGIA; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OXYCODONE; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 77949535605     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2010.0003     Document Type: Article

References (29)

1. Rindfleisch JA, Muller D: Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2005; 72(6): 1037-1047.
2. Brent LH: Inflammatory arthritis: An overview for primary care physicians. Postgrad Med. 2009; 121(2): 148-162.
3. Alamanos Y, Drosos AA: Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005; 4(3): 130-136.
4. Leeb BF, Haindl PM, Maktari A, et al.: Disease activity score-28 values differ considerably depending on patient's pain perception and sex. J Rheumatol. 2007; 34(12): 2382-2387.
5. Odegȧrd S, Finset A, Mowinckel P, et al.: Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis. Ann Rheum Dis. 2007; 66(9): 1195-1201.
6. Deyo RA: Drug therapy for back pain: Which drugs help which patients? Spine. 1996; 21: 2840-50.
7. Mukherjee D, Nissen SE, Topol EJ: Risk of cardio-vascular events associated with selective COX-2 inhibitors. JAMA. 2001; 286: 954-959.
8. Dequeker J: NSAIDs/corticosteroids-Primum non nocere. Adv Exp Med Biol. 1999; 455: 319-325.
9. Kirwan JR; Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med. 1995; 333: 142-146.
10. Chou R, Qaseem A, Snow V, et al.: Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007; 147: 478-491.
11. Warfield CA: Controlled-release morphine tablets in patients wim chronic cancer pain: A narrative review of controlled clinical trials. Cancer. 1998; 82: 2299-2306.
12. Weinstein SM, Shi M, Buckley BJ, et al.: Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain. Clin Ther. 2006; 28: 86-98.
13. Pergolizzi J, Böger RH, Budd K, et al.: Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008; 8(4): 287-313.
14. Solomon DH, Avorn J, Wang PS, et al.: Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum. 2006; 55: 35-41.
15. Raffaeli W, Provinciali M, Di Stefano G, et al.: The immune system and analgesics. In Raj P, Erdine S, Niv D, et al. (eds.): Management of Pain. In A world Perspective. Bologna: Monduzzi Editore Press, 1995: 85-93.
16. Millett PJ, Gobezie R, Boykin RE: Shoulder osteoarthritis: Diagnosis and management. Am Fam Physician. 2008; 78(5): 605-611.
17. Barron MC, Rubin BR: Managing osteoarthritic knee pain. J Am Osteopath Assoc. 2007; 107(10 Suppl 6): ES21-ES27.
18. Caldwell JR, Hale ME, Boyd RE, et al.: Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: A double blind, randomized, multicenter, placebo controlled trial. J Rheumatol. 1999; 26(4): 862-869.
19. Lee EY, Lee EB, Park BJ, et al.: Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: A 1-week, randomized, double-blind, placebo-controlled trial. Clin Ther. 2006; 28(12): 2052-2060.
20. Connelly M, Schanberg L: Opioid therapy for the treatment of refractory pain in children with juvenile rheumatoid arthritis. Nat Clin Pract Rheumatol. 2006; 2(12): 636-637.
21. Fries JF, Spitz PW, Kraines RG, et al.: Measurement of patient outcome in arthritis. Arthritis Rheum. 1980; 23: 137-145.
22. Sokka T, Makinen H: Improving outcomes in rheumatoid arthritis: What determines decisions to change ineffective therapy? J Rheumatol. 2006; 33: 1213-1215.
23. Wells G, Becker JC, Teng J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009; 68(6): 954-960.
24. Huskisson EC: Measurement of pain. Lancet. 1974; 2: 1127-1131.
25. American College of Rheumatology Committee to Reevaluate Improvement Criteria: A proposed revision to the ACR20: The hybrid measure of American College of Rheumatology response. Arthritis Rheum. 2007; 57: 193-202.
26. Thomas J, Straus WL, Bloom BS: Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Am J Gastroenterol. 2002; 97(9): 2215-2219.
27. Adams NJ, Plane MB, Fleming MF, et al.: Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001; 22(3): 791-796.
28. Raffaeli W, Salmosky-Dekel BG: Biological consequences of long-term intrathecal administration of opiods. Minerva Anestesiol. 2005; 71: 475-478.
29. Corsinovi L, Martinelli E, Fonte G, et al.: Efficacy of oxycodone/acetaminophen and codeine/acetaminophen vs. conventional therapy in elderly women with persistent, moderate to severe osteoarthritis-related pain. Arch Gerontol Geriatr. 2009; 49(3): 378-382.